中国卒中杂志 ›› 2021, Vol. 16 ›› Issue (02): 101-118.DOI: 10.3969/j.issn.1673-5765.2021.02.001
王拥军,熊云云,杨佳蕾,李光硕,闫然,王文洁,瓮佳旭,上官艺
收稿日期:
2021-02-01
出版日期:
2021-02-20
发布日期:
2021-02-20
通讯作者:
王拥军 yongjunwang@ncrcnd.org.cn
Received:
2021-02-01
Online:
2021-02-20
Published:
2021-02-20
王拥军,熊云云,杨佳蕾,李光硕,闫然,王文洁,瓮佳旭,上官艺. 卒中:回眸2020[J]. 中国卒中杂志, 2021, 16(02): 101-118.
WANG Yong-Jun, XIONG Yun-Yun, YANG Jia-Lei, LI Guang-Shuo,YAN Ran, WANG Wen-Jie, WENG Jia-Xu, SHANGGUAN Yi. Highlights on Stroke Research in 2020[J]. Chinese Journal of Stroke, 2021, 16(02): 101-118.
[1] VOS T,LIM S S,ABBAFATI C,et al. Globalburden of 369 diseases and injuries in 204 countriesand territories,1990–2019:a systematic analysis forthe Global Burden of Disease Study 2019[J]. Lancet,2020,396(10258):1204-1222.[2] PHAN T G,HASEEB A,BEARE R,et al. Googlingthe lifetime risk of stroke around the world[J/OL].F11:729[2021-02-01]. https://doi.org/10.3389/f rontNeurol,2020,neur.2020.00729.[3] KRISHNAMURTHI R V,IKEDA T,FEIGIN VL. Global,regional and country-specific burdenof ischaemic stroke,intracerebral haemorrhageand subarachnoid haemorrhage:a systematicanalysis of the global burden of disease study 2017[J].Neuroepidemiology,2020,54(2):171-179.[4] WANG Y J,LI Z X,GU H Q,et al. China strokestatistics 2019:a report from the national centerfor healthcare quality management in neurologicaldiseases,China National Clinical Research Center forNeurological Diseases,the Chinese Stroke Association,National Center for Chronic and Non-communicableDisease Control and Prevention,Chinese Center forDisease Control and Prevention and Institute for GlobalNeuroscience and Stroke Collaborations[J]. StrokeVasc Neurol,2020,5(3):211-239.[5] ILIFF J J,WANG M,LIAO Y,et al. A paravascularpathway facilitates CSF flow through the brainparenchyma and the clearance of interstitial solutes,including amyloid β[J/OL]. Sci Transl Med,2012,4(147):147ra111[2021-02-01]. https://doi.org/10.1126/scitranslmed.3003748.[6] LOUVEAU A,SMIRNOV I,KEYES T J,et al.Structural and functional features of central nervoussystem lymphatic vessels[J]. Nature,2015,523(7560):337-341.[7] MESTRE H,DU T,SWEENEY A M,et al.Cerebrospinal fluid influx drives acute ischemictissue swelling[J/OL]. Science,2020,367(6483):eaax7171[2021-02-01]. https://doi.org/10.1126/science.aax7171.[8] DHAR R. Automated quantitative assessmentof cerebral edema after ischemic stroke usingCSF volumetrics[J/OL]. Neurosci Lett,2020,724:134879[2021-02-01]. https://doi.org/10.1016/j.neulet.2020.134879.[9] DHAR R,CHEN Y,HAMZEHLOO A,et al.Reduction in cerebrospinal fluid volume as an earlyquantitative biomarker of cerebral edema afterischemic stroke[J]. Stroke,2020,51(2):462-467.[10] NAGANAWA S,TAOKA T. The glymphatic system:areview of the challenges in visualizing its structure andfunction with MR imaging[J/OL]. Magn Reson MedSci,2020[2021-02-01]. https://doi.org/10.2463/mrms.rev.2020-0122.[11] LANGHORNE P,AUDEBERT H J,CADILHAC D A,et al. Stroke systems of care in high-income countries:what is optimal?[J]. Lancet,2020,396(10260):1433-1442.[12] PANDIAN J D,KALKONDE Y,SEBASTIAN I A,etal. Stroke systems of care in low-income and middleincomecountries:challenges and opportunities[J].Lancet,2020,396(10260):1443-1451.[13] MARTINS S O,MONT'ALVERNE F,REBELLO LC,et al. Thrombectomy for stroke in the public health care system of brazil[J]. N Engl J Med,2020,382(24):2316-2326.[14] YANG P F,ZHANG Y W,ZHANG L,et al.Endovascular thrombectomy with or withoutintravenous alteplase in acute stroke[J]. N Engl JMed,2020,382(21):1981-1993.[15] WANG Y T,WU X,ZHU C C,et al. Bridgingthrombolysis achieved better outcomes than directthrombectomy after large vessel occlusion:anupdated meta-analysis[J]. Stroke,2021,52(1):356-365.[16] CAMPBELL B C V,MITCHELL P J,CHURILOVL,et al. Tenecteplase versus alteplase beforethrombectomy for ischemic stroke[J]. N Engl J Med,2018,378(17):1573-1582.[17] CAMPBELL B C V,MITCHELL P J,CHURILOVL,et al. Effect of intravenous tenecteplase doseon cerebral reperfusion before thrombectomy inpatients with large vessel occlusion ischemic stroke:the EXTEND-IA TNK part 2 randomized clinicaltrial[J]. JAMA,2020,323(13):1257-1265.[18] THOMALLA G,BOUTITIE F,MA H,et al.Intravenous alteplase for stroke with unknown timeof onset guided by advanced imaging:systematicreview and meta-analysis of individual patientdata[J]. Lancet,2020,396(10262):1574-1584.[19] HILL M D,GOYAL M,MENON B K,et al.Efficacy and safety of nerinetide for the treatmentof acute ischaemic stroke(ESCAPE-NA1):amulticentre,double-blind,randomised controlledtrial[J]. Lancet,2020,395(10227):878-887.[20] TARIQ S,SAH R G,CHAN L,et al. Recanalizationfollowing endovascular treatment and imagingof perfusion,regional infarction and atrophy tounderstand stroke evolution-NA1(REPERFUSENA1)[J]. Int J Stroke,2020,15(3):343-349.[21] WANG Y J,WANG Y L,ZHAO X Q,et al.Clopidogrel with aspirin in acute minor stroke ortransient ischemic attack[J]. N Engl J Med,2013,369(1):11-19.[22] JOHNSTON S C,AMARENCO P,DENISON H,etal. Ticagrelor and aspirin or aspirin alone in acuteischemic stroke or TIA[J]. N Engl J Med,2020,383(3):207-217.[23] DING L L,LIU C,LI Z X,et al. Incorporatingartificial intelligence into stroke care and research[J/OL]. Stroke,2020,51(12):e351-e354[2021-02-01].https://doi.org/10.1161/strokeaha.120.031295.[24] RIVERA S C,LIU X,CHAN A W,et al. Guidelinesfor clinical trial protocols for interventions involvingartificial intelligence:the SPIRIT-AI extension[J].Nat Med,2020,26(9):1351-1363.[25] LIU X,CRUZ RIVERA S,MOHER D,et al.Reporting guidelines for clinical trial reports forinterventions involving artificial intelligence:theCONSORT-AI extension[J]. Nat Med,2020,26(9):1364-1374.[26] 熊云云,李子孝,丁玲玲,等. 基于人工智能干预措施的临床试验方案指南:SPIRIT-AI扩展[J]. 中国卒中杂志,2020,15(11):1228-1238.[27] 李子孝,熊云云,丁玲玲,等. 人工智能干预性临床试验报告指南:CONSORT-AI扩展[J]. 中国卒中杂志,2020,15(12):1327-1336.[28] KANSAGRA A P,GOYAL M S,HAMILTON S,etal. Collateral effect of Covid-19 on stroke evaluationin the United States[J]. N Engl J Med,2020,383(4):400-401.[29] ZHOU Y F,HONG C D,CHANG J,et al.Intravenous thrombolysis for acute ischaemic strokeduring COVID-19 pandemic in Wuhan,China:amulticentre,retrospective cohort study[J]. J NeurolNeurosurg Psychiatry,2021,92(2):226-228.[30] KERLEROUX B,FABACHER T,BRICOUT N,etal. Mechanical thrombectomy for acute ischemicstroke amid the COVID-19 outbreak:decreasedactivity,and increased care delays[J]. Stroke,2020,51(7):2012-2017.[31] AHA/ASA Stroke Council Leadership. Temporaryemergency guidance to US stroke centers during thecoronavirus disease 2019(COVID-19)pandemic:onbehalf of the American Heart Association/AmericanStroke Association Stroke Council Leadership[J].Stroke,2020,51(6):1910-1912.[32] TSIVGOULIS G,KATSANOS A H,ORNELLOR,et al. Ischemic stroke epidemiology during theCOVID-19 pandemic:navigating uncharted waterswith changing tides[J]. Stroke,2020,51(7):1924-1926.[33] LEE M H,PERL D P,NAIR G,et al. Microvascularinjury in the brains of patients with Covid-19[J]. NEngl J Med,2021,384(5):481-483.[34] IADECOLA C,ANRATHER J,KAMEL H. Effectsof COVID-19 on the nervous system[J]. Cell,2020,183(1):16-27.[35] KASHYAP V S,SCHNEIDER P A,FOTEH M,etal. Early outcomes in the ROADSTER 2 study oftranscarotid artery revascularization in patients withsignificant carotid artery disease[J]. Stroke,2020,51(9):2620-2629. |
[1] | 曹黎明, 任力杰. 急性缺血性卒中诊疗技术的进展与展望[J]. 中国卒中杂志, 2024, 19(9): 983-989. |
[2] | 符鹏程, 曹黎明, 朱佳倩, 赵桂玉, 徐格林. 大动脉粥样硬化性缺血性卒中再灌注治疗的研究进展[J]. 中国卒中杂志, 2024, 19(9): 1004-1011. |
[3] | 张丽苹, 曹黎明, 肖楠, 廖雨琦, 池枫, 余艳妮, 任力杰. 纳米材料在缺血性卒中诊疗中的研究进展及挑战[J]. 中国卒中杂志, 2024, 19(9): 1012-1017. |
[4] | 姜河, 王珵, 陈祥华, 许春香. 五种院前卒中筛查量表对院内急性大血管闭塞性缺血性卒中的预测价值[J]. 中国卒中杂志, 2024, 19(9): 1018-1024. |
[5] | 王晓蕊, 骆嵩, 邹良玉, 屈洪党, 崔雪, 赵玉洁. 嗜酸性粒细胞与单核细胞比值预测急性缺血性卒中患者静脉溶栓预后的价值研究 [J]. 中国卒中杂志, 2024, 19(9): 1025-1033. |
[6] | 王铄, 余苹, 张宁, 王春雪. 2013—2023年缺血性卒中与睡眠相关性研究的文献计量学分析 [J]. 中国卒中杂志, 2024, 19(9): 1040-1047. |
[7] | 周宏宇, 李子孝, 王拥军. 基于影像组学预测大脑年龄与缺血性卒中的研究进展[J]. 中国卒中杂志, 2024, 19(9): 1066-1076. |
[8] | 阿娜古丽·阿不拉尼压孜, 吴晓欣, 李骄星, 李竹浩, 盛文利. 急性缺血性卒中磁敏感血管征影响因素及临床应用的研究进展[J]. 中国卒中杂志, 2024, 19(9): 1077-1085. |
[9] | 杨金波, 张聪. 高分辨率血管壁成像在缺血性卒中患者中的应用进展[J]. 中国卒中杂志, 2024, 19(9): 1086-1093. |
[10] | 吴春艳, 尹雅诗, 王广志, 岳奎涛. 急性缺血性卒中不同时间窗影像学评价及应用进展[J]. 中国卒中杂志, 2024, 19(9): 1094-1101. |
[11] | 王也, 魏宸铭, 李秀丽, 武剑. 多元化教学模式在大学附属教学医院卒中绿色通道培训中的应用[J]. 中国卒中杂志, 2024, 19(9): 1102-1109. |
[12] | 单凯, 赵梦, 王春娟, 李子孝, 王晓岩. 卒中及共患疾病诊疗模式探索与实践 [J]. 中国卒中杂志, 2024, 19(8): 863-865. |
[13] | 张梦若, 徐守臣, 隋翠翠, 李玉奎, 王雪莉. 下肢康复机器人联合头针治疗对老年缺血性卒中患者步行效率和协调功能影响调查 [J]. 中国卒中杂志, 2024, 19(8): 902-908. |
[14] | 薛明月, 张慧鑫, 苏丹, 李丽霞, 李晶玮, 李虹. 缺血性卒中患者服药依从性影响因素分析 [J]. 中国卒中杂志, 2024, 19(8): 909-914. |
[15] | 吴娱倩, 张玉梅, 臧大维, 范小伟, 王安心, 张晓丽, 孟霞. 上肢动作研究测试量表评定亚急性期缺血性卒中患者偏瘫侧上肢及手功能的信效度和敏感性研究 [J]. 中国卒中杂志, 2024, 19(8): 915-923. |
阅读次数 | ||||||
全文 |
|
|||||
摘要 |
|
|||||